To date, many studies on various cancer cell lines have reported the additive or synergistic effects of combined treatment with retinoids and inhibitors of lipoxygenases (LOX) [21-24] or cyclooxygenases (COX) [25-27]. This evidence concerns the gene LOX and cancer.